Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 3137Neoplasms 2474Carcinoma, Non-Small-Cell Lung 1883Prostatic Neoplasms 1641Colorectal Neoplasms 1432Lung Neoplasms 1308Multiple Myeloma 937Neoplasm Metastasis 926Leukemia, Myeloid, Acute 885Pancreatic Neoplasms 860Ovarian Neoplasms 814Melanoma 791Carcinoma, Hepatocellular 743Stomach Neoplasms 647Recurrence 640Brain Neoplasms 640Squamous Cell Carcinoma of Head and Neck 638Head and Neck Neoplasms 609Glioblastoma 573Uterine Cervical Neoplasms 549Lymphoma 549Triple Negative Breast Neoplasms 514Precursor Cell Lymphoblastic Leukemia-Lymphoma 511Carcinoma, Renal Cell 504Endometrial Neoplasms 467Hematologic Neoplasms 464Urinary Bladder Neoplasms 462Colonic Neoplasms 447Lymphoma, Non-Hodgkin 437Sarcoma 436

Interventions

Lasers, Solid-State 1Lasers 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Port-Wine Stain × 1 year × Clear all
NCT01364857 2025-12-22

CONAPE

University Hospital, Tours

Phase NA Completed
150 enrolled

Klippel-Trenaunay-Weber Syndrome, Sturge-Weber Syndrome, Port-Wine Stain

NCT07183644 2025-09-19

Maximizing Laser Therapy Success for Port-Wine Birthmarks in Pediatric Patients

University of Texas Southwestern Medical Center

Phase NA Not yet recruiting
200 enrolled

Hemangioma, Capillary, Port-Wine Stain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡